Click Here for 5% Off Your First Aladdin Purchase!

GS-444217 - 98%, high purity , CAS No.1262041-49-5, Inhibitor of mitogen-activated protein kinase kinase kinase 5

  • Moligand™
  • ≥98%
Item Number
G412159
Grouped product items
SKUSizeAvailabilityPrice Qty
G412159-5mg
5mg
In stock
$107.90
G412159-10mg
10mg
In stock
$162.90
G412159-25mg
25mg
In stock
$271.90
G412159-50mg
50mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$489.90
G412159-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$815.90

ASK Inhibitors

Basic Description

SynonymsGS444217;GS 444217;ASK1-IN-1
Specifications & Purity98%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of mitogen-activated protein kinase kinase kinase 5
Product Description

Information

GS-444217 GS-444217 (ASK1-IN-1) is a potent, selective, orally available and ATP-competitive inhibitor of ASK1 (apoptosis signal-regulating kinase 1) with IC50 of 2.87 nM.


Targets

ASK1 (Cell-free assay) 2.87 nM

Product Properties

ALogP2.587
HBD Count1
Rotatable Bond6

Associated Targets

MAP3K5 Tchem Mitogen-activated protein kinase kinase kinase 5 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 4-(4-cyclopropylimidazol-1-yl)-N-[3-(4-cyclopropyl-1,2,4-triazol-3-yl)phenyl]pyridine-2-carboxamide
INCHI InChI=1S/C23H21N7O/c31-23(20-11-19(8-9-24-20)29-12-21(25-13-29)15-4-5-15)27-17-3-1-2-16(10-17)22-28-26-14-30(22)18-6-7-18/h1-3,8-15,18H,4-7H2,(H,27,31)
InChi Key ZGCMQKWOUIMBEP-UHFFFAOYSA-N
Canonical SMILES C1CC1C2=CN(C=N2)C3=CC(=NC=C3)C(=O)NC4=CC=CC(=C4)C5=NN=CN5C6CC6
Isomeric SMILES C1CC1C2=CN(C=N2)C3=CC(=NC=C3)C(=O)NC4=CC=CC(=C4)C5=NN=CN5C6CC6
PubChem CID 57504987
MeSH Entry Terms 4-(4-cyclopropyl-1H-imidazol-1-yl)-N-(3-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)phenyl)picolinamide;4-(4-cyclopropylimidazol-1-yl)-N-(3-(4-cyclopropyl-1,2,4-triazol-3-yl)phenyl)pyridine-2-carboxamide;Ask1-IN-1;GS-444217
Molecular Weight 411.46

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

5 results found

Lot NumberCertificate TypeDateItem
F2214025Certificate of AnalysisMay 31, 2022 G412159
F2214026Certificate of AnalysisMay 31, 2022 G412159
F2214027Certificate of AnalysisMay 31, 2022 G412159
F2214029Certificate of AnalysisMay 31, 2022 G412159
F2214030Certificate of AnalysisMay 31, 2022 G412159

Chemical and Physical Properties

SolubilitySolubility (25°C) In vitro DMSO: 60 mg/mL (145.82 mM); Water: Insoluble; Ethanol: Insoluble;
DMSO(mg / mL) Max Solubility60
DMSO(mM) Max Solubility145.822194137948
Water(mg / mL) Max Solubility<1

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

Related Documents

References

1. Tesch GH, Ma FY, Han Y, Liles JT, Breckenridge DG, Nikolic-Paterson DJ.  (2015)  ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice..  Diabetes,  64  (11): (3903-13).  [PMID:26180085]
2. Budas GR, Boehm M, Kojonazarov B, Viswanathan G, Tian X, Veeroju S, Novoyatleva T, Grimminger F, Hinojosa-Kirschenbaum F, Ghofrani HA et al..  (2018)  ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension..  Am J Respir Crit Care Med,  197  (3): (373-385).  [PMID:28910144]

Solution Calculators